Sugi Predict

Sugi Predict / Compounds / SCHEMBL357140

SCHEMBL357140

SCHEMBL357140

CCCCn1cc[n+](C)c1.O=S(=O)([O-])C(F)(F)C(F)F

nearest known ligand 0.59

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.51
▸ APAF1 O14727 1/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ PLA2G1B P04054 1/20 0.51
▸ HSP90AA1 P07900 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ ATG4B Q9Y4P1 1/20 0.51
▸ FDPS P14324 18/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1736110 0.95 MEN1 (0.59) MEN1APAF1NPC1PLA2G1BHSP90AA1
SCHEMBL1735067 0.95 MEN1 (0.59) MEN1APAF1NPC1PLA2G1BHSP90AA1
SCHEMBL358008 0.95 MEN1 (0.59) MEN1APAF1NPC1PLA2G1BHSP90AA1
SCHEMBL1858368 0.95 MEN1 (0.59) MEN1APAF1NPC1PLA2G1BHSP90AA1
SCHEMBL1735957 0.95 MEN1 (0.59) MEN1APAF1NPC1PLA2G1BHSP90AA1
SCHEMBL1736115 0.95 MEN1 (0.59) MEN1APAF1NPC1PLA2G1BHSP90AA1
SCHEMBL16107838 0.92 MEN1 (0.43) MEN1APAF1NPC1PLA2G1BHSP90AA1
SCHEMBL358056 0.90 MEN1 (0.49) MEN1APAF1NPC1PLA2G1BHSP90AA1
Trifluoromethanesulfonic Acid SCHEMBL294105 0.88 MEN1 (0.58) MEN1APAF1NPC1PLA2G1BHSP90AA1
Trifluoromethanesulfonic Acid SCHEMBL29390371 0.88 MEN1 (0.58) MEN1APAF1NPC1PLA2G1BHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2021276-B1 PROCESS FOR PURIFYING PERFLUORINATED PRODUCTS DU PONT (US) 2013-07-17 — — EP claimed
EP-1954680-B1 IONIC LIQUIDS DU PONT (US) 2012-05-23 — — EP claimed
US-20120011886-A1 IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS E. I. DU PONT DE NEMOURS AND COMPANY 2012-01-19 — — US claimed
US-20200129922-A1 METHOD OF REDUCING CONCENTRATION OF FLUORINE-CONTAINING COMPOUND IN SAMPLE SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-04-30 — — US disclosed
EP-3080859-B1 NA BASED SECONDARY BATTERY FIELD UPGRADING USA (US) 2020-04-08 — — EP disclosed
US-10367226-B2 Na based secondary battery SK INNOVATION CO., LTD. (KR) 2019-07-30 — — US disclosed
US-9780380-B2 Current collector for battery and secondary battery comprising the same SK INNOVATION CO., LTD. (KR) 2017-10-03 — — US disclosed
US-9755270-B2 Sodium secondary battery including graphite felt having pore channels formed therein SK INNOVATION CO., LTD. (KR) 2017-09-05 — — US disclosed
US-9608274-B2 Sodium secondary battery including graphite felt as current collector SK INNOVATION CO., LTD. (KR) 2017-03-28 — — US disclosed
US-20160315345-A1 NA BASED SECONDARY BATTERY FIELD UPGRADING USA, INC. 2016-10-27 — — US disclosed
EP-3080859-A1 NA BASED SECONDARY BATTERY SK Innovation Co., Ltd. (KR) 2016-10-19 — — EP disclosed
US-20070131535-A1 Utilizing ionic liquids for hydrofluorocarbon separation THE CHEMOURS COMPANY FC, LLC 2007-06-14 — — US disclosed
US-20070100181-A1 Olefin isomerization E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 — — US disclosed
US-20070100184-A1 Alkylation of aromatic compounds E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 — — US disclosed
WO-2007050492-A1 ALKYLATION OF AROMATIC COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-05-03 — — WO disclosed
US-20070066854-A1 Preparation of polytrimethylene ether glycol and copolymers thereof THE CHEMOURS COMPANY FC, LLC 2007-03-22 — — US disclosed
US-20070066852-A1 Preparation of poly(tetramethylene) glycol THE CHEMOURS COMPANY FC, LLC 2007-03-22 — — US disclosed
US-20070066822-A1 Ionic liquids THE CHEMOURS COMPANY FC, LLC 2007-03-22 — — US disclosed
US-20070019708-A1 Hybrid vapor compression-absorption cycle E. I. DU PONT DE NEMOURS AND COMPANY 2007-01-25 — — US disclosed
US-20060197053-A1 Absorption cycle utilizing ionic liquid as working fluid E. I. DU PONT DE NEMOURS AND COMPANY 2006-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070100184-A1 Alkylation of aromatic compounds TYR, ALK, AHR MEN1 1923/4885APAF1 329/4885NPC1 2753/4885
US-20070066854-A1 Preparation of polytrimethylene ether glycol and copolymers thereof PARG, PTGES3, PGD MEN1 1773/4885APAF1 1602/4885NPC1 4723/4885
US-20070100181-A1 Olefin isomerization OSBP, OXER1, ALOX12 MEN1 3487/4885APAF1 1394/4885NPC1 518/4885
US-20070131535-A1 Utilizing ionic liquids for hydrofluorocarbon separation AQP3, AQP1, SLC26A3 MEN1 995/4885APAF1 1757/4885NPC1 311/4885
US-20070066822-A1 Ionic liquids AFF2, AFF1, ZYX MEN1 1207/4885APAF1 3882/4885NPC1 4270/4885
US-20070066852-A1 Preparation of poly(tetramethylene) glycol PARG, PUF60, TPR MEN1 322/4885APAF1 2585/4885NPC1 2084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.